| Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries G Bellani, JG Laffey, T Pham, E Fan, L Brochard, A Esteban, L Gattinoni, ... Jama 315 (8), 788-800, 2016 | 4711 | 2016 |
| Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study JG Laffey, G Bellani, T Pham, E Fan, F Madotto, EK Bajwa, L Brochard, ... Intensive care medicine 42, 1865-1876, 2016 | 340 | 2016 |
| Stress and burnout in health care workers during COVID-19 pandemic: validation of a questionnaire N Talaee, M Varahram, H Jamaati, A Salimi, M Attarchi, ... Journal of Public Health, 1-6, 2020 | 295 | 2020 |
| Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series SMR Hashemian, R Aliannejad, M Zarrabi, M Soleimani, M Vosough, ... Stem cell research & therapy 12, 1-12, 2021 | 175 | 2021 |
| Anti-inflammatory effects of lactobacillus rahmnosus and bifidobacterium breve on cigarette smoke activated human macrophages E Mortaz, IM Adcock, FLM Ricciardolo, M Varahram, H Jamaati, ... PLoS One 10 (8), e0136455, 2015 | 138 | 2015 |
| Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries T Abe, F Madotto, T Pham, I Nagata, M Uchida, N Tamiya, K Kurahashi, ... Critical care 22, 1-16, 2018 | 135 | 2018 |
| Nitric oxide in the pathogenesis and treatment of tuberculosis H Jamaati, E Mortaz, Z Pajouhi, G Folkerts, M Movassaghi, ... Frontiers in microbiology 8, 2008, 2017 | 118 | 2017 |
| Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study JG Laffey, F Madotto, G Bellani, T Pham, E Fan, L Brochard, P Amin, ... The Lancet Respiratory Medicine 5 (8), 627-638, 2017 | 115 | 2017 |
| Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial P Tabarsi, S Barati, H Jamaati, S Haseli, M Marjani, A Moniri, Z Abtahian, ... International immunopharmacology 90, 107205, 2021 | 96 | 2021 |
| Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial F Dastan, SA Nadji, A Saffaei, M Marjani, A Moniri, H Jamaati, ... International immunopharmacology 85, 106688, 2020 | 90 | 2020 |
| No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial H Jamaati, SMR Hashemian, B Farzanegan, M Malekmohammad, ... European Journal of Pharmacology 897, 173947, 2021 | 85 | 2021 |
| Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis MV Maddali, M Churpek, T Pham, E Rezoagli, H Zhuo, W Zhao, J He, ... The lancet respiratory medicine 10 (4), 367-377, 2022 | 74 | 2022 |
| Increased serum levels of soluble TNF-α receptor is associated with ICU mortality in COVID-19 patients E Mortaz, P Tabarsi, H Jamaati, N Dalil Roofchayee, NK Dezfuli, ... Frontiers in Immunology 12, 592727, 2021 | 70 | 2021 |
| Effect of the Cardio First Angel™ device on CPR indices: a randomized controlled clinical trial A Vahedian-Azimi, M Hajiesmaeili, A Amirsavadkouhi, H Jamaati, M Izadi, ... Critical Care 20, 1-8, 2016 | 70 | 2016 |
| Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study F Madotto, T Pham, G Bellani, LD Bos, FD Simonis, E Fan, A Artigas, ... Intensive care medicine 44, 564-577, 2018 | 66 | 2018 |
| Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ... International immunopharmacology 88, 106869, 2020 | 63 | 2020 |
| Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study T Pham, L Heunks, G Bellani, F Madotto, I Aragao, G Beduneau, ... The Lancet Respiratory Medicine 11 (5), 465-476, 2023 | 56 | 2023 |
| COVID-19: molecular and cellular response SD Alipoor, E Mortaz, H Jamaati, P Tabarsi, H Bayram, M Varahram, ... Frontiers in cellular and infection microbiology 11, 563085, 2021 | 53 | 2021 |
| A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol H Jamaati, F Dastan, P Tabarsi, M Marjani, A Saffaei, SMR Hashemian Iranian Journal of Pharmaceutical Research: IJPR 19 (1), 31, 2020 | 51 | 2020 |
| Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS) SMR Hashemian, N Shafigh, G Afzal, H Jamaati, P Tabarsi, M Marjani, ... Pulmonology 27 (6), 486-492, 2021 | 48 | 2021 |
